Origen de la red de primer grado Ingo Broda.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
IMD Natural Solutions GmbH
 IMD Natural Solutions GmbH Food RetailRetail Trade IMD Natural Solutions GmbH develops preservative agents. Its product, INS Glycolipid, is a natural mushroom extract that is water soluble and can be used for preservation applications. The company was founded in 2012 and is headquartered in Dortmund, Germany.
2
| Subsidiary | Food Retail | 2 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Ingo Broda a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Gottingen | College/University | Doctorate Degree | |
S Direkt-Marketing GmbH & Co. KG
 S Direkt-Marketing GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services Part of Saalesparkasse, S Direkt-Marketing GmbH & Co. KG is a German company that specializes in telephone campaigns for product sales and efficient outbound campaigns for savings banks. The company is based in Halle, Germany. The company also design new platform offers and provide IT infrastructure, design interfaces to cooperation partners and content, and make fintech applications usable for savings banks. The CEOs of the company are Thomas Henkel, Ingo van Uehm. S Direkt-Marketing offers holistic solutions from a single source for savings banks and network partners, including media customer services, innovative added value, and new digital services. The company offers attractive positions for modern challenges. | Miscellaneous Commercial Services | Chief Executive Officer | |
TARGOS Molecular Pathology GmbH
 TARGOS Molecular Pathology GmbH BiotechnologyHealth Technology Part of Discovery Life Sciences LLC, TARGOS Molecular Pathology GmbH is a German company that provides biomarker services. The company is based in Kassel, Germany. The company was founded in 2005 by Reinhard Büttner, Josef Rüschoff, Thomas Henkel. Thomas Henkel has been the CEO since 2005. TARGOS Molecular Pathology was acquired by Discovery Life Sciences LLC on May 18, 2021. | Biotechnology | Chief Executive Officer |
Estadísticas
Internacional
| Alemania | 7 |
Sectorial
| Health Technology | 4 |
| Commercial Services | 3 |
| Consumer Services | 2 |
Operativa
| Chief Executive Officer | 4 |
| Corporate Officer/Principal | 3 |
| Founder | 2 |
| President | 1 |
| Doctorate Degree | 1 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Thomas Henkel | 7 |
| Amalia Schmidt | 1 |
- Bolsa de valores
- Insiders
- Ingo Broda
- Conexiones Empresas
